In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene

BACKGROUND: Dihydroartemisinin-piperaquine is a new ACT that is administered as single daily dose for three days and has been demonstrated to be tolerated and highly effective for the treatment of uncomplicated Plasmodium falciparum malaria. Piperaquine was used alone to replace chloroquine as the f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Malar J
Main Authors: Pascual, Aurélie, Madamet, Marilyn, Bertaux, Lionel, Amalvict, Rémy, Benoit, Nicolas, Travers, Dominique, Cren, Julien, Taudon, Nicolas, Rogier, Christophe, Parzy, Daniel, Pradines, Bruno
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225597/
https://ncbi.nlm.nih.gov/pubmed/24274185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-431
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados